Improved immunohistochemical evaluation of micrometastases in sentinel lymph nodes of cutaneous melanoma with 'MCW melanoma cocktail' - A mixture of monoclonal antibodies to MART-I, melan-A, and tyrosinase

BMC Cancer

Volumn 3, Issue , 2003, Pages

  Shidham, Vinod B ^a   Qi, Dan ^a   Rao, R Nagarjun ^a   Acker, Scott M ^a   Chang, Chung Che ^a   Kampalath, Bal ^a   Dawson, Glen ^a   Machhi, Jinobya K ^a   Komorowski, Richard A ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

HMB 45; Immunohistochemistry; Lymphadenectomy; MART I; Melan A; Melanoma; Melanoma cocktail; Micrometastasis; S 100 protein; Sentinel lymph node; Tyrosinase

Indexed keywords

MELAN A; MONOCLONAL ANTIBODY; MONOPHENOL MONOOXYGENASE; PROTEIN S 100; DIAGNOSTIC AGENT; MLANA PROTEIN, HUMAN; TUMOR ANTIGEN; TUMOR PROTEIN;

ARTICLE; BREAST CARCINOMA; CLINICAL ARTICLE; CONTROLLED STUDY; COST CONTROL; DIAGNOSTIC ACCURACY; EVALUATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LYMPH NODE METASTASIS; MELANOMA; NEVUS; REPRODUCIBILITY; SENSITIVITY ANALYSIS; SENTINEL LYMPH NODE; STATISTICAL ANALYSIS; TISSUE SECTION; CHEMISTRY; IMMUNOLOGY; LYMPH NODE; METABOLISM; METHODOLOGY; OBSERVER VARIATION; PATHOLOGY; SENTINEL LYMPH NODE BIOPSY; SKIN TUMOR;

ANTIBODIES, MONOCLONAL; ANTIGENS, NEOPLASM; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPH NODES; LYMPHATIC METASTASIS; MART-1 ANTIGEN; MELANOMA; MONOPHENOL MONOOXYGENASE; NEOPLASM PROTEINS; OBSERVER VARIATION; REPRODUCIBILITY OF RESULTS; SENTINEL LYMPH NODE BIOPSY; SKIN NEOPLASMS;

EID: 3042841017     PISSN: 14712407     EISSN: None     Source Type: Journal    
DOI: 10.1186/1471-2407-3-15     Document Type: Article

References (31)

1. Crowley N The case against elective lymphadenectomy Surg Clin North Am 1992, 1:223-46
2. Heller R, Becker J, Wasselle J, Baekey P, Cruse W and Wells K Detection of submicroscopic lymph node metastases in patients with melanoma Arch Surg 1991, 126:1455-60
3. Miliotes G, Albertini J, Berman C, Heller R, Messina J, Glass F, Cruse W, Rapaport D, Puleo C, Fenske N, Petsoglou C, Deconti R, Lyman G and Reintgen D The tumor biology of melanoma nodal metastases Am Surg 1996, 62:81-88
4. Morton D, Wen D-R, Wong J, Economou JS, Cagle LA and Storm FK Technical details of intraoperative lymphatic mapping for early stage melanoma Arch Surg 1992, 127:392-9
5. Reintgen D, Cruse CW, Wells K, Berman C, Fenske N and Glass F The orderly progression of melanoma nodal metastases Ann Surg 1994, 220:759-67
6. Shidham VB, Qi D, Acker S, Kampalath B, Chang C, George V and Komorowski R Evaluation of micrometastases in sentinel lymph nodes of cutaneous melanoma: Higher diagnostic accuracy with Melan-A and MART-1 compared to S-100 protein and HMB-45 Am J Surg Pathol 2001, 25:1039-46
7. Tanabe K and Reintgen D The role of sentinel lymph node mapping for melanoma Adv Surg 1998, 31:79-103
8. Yu LL, Flotte TJ, Tanabe KK, Gadd MA, Cosimi AB, Sober AJ, Mihm MC and Duncan LM Detection of microscopic melanoma metastases in sentinel lymph nodes Cancer 1999, 86:617-27
9. Brady MS and Coit DG Sentinel lymph node evaluation in melanoma Arch Dermatol 1997, 133:1014-20
10. Gershenwald JE, Colome MI, Lee JE, Mansfield PF, Tseng C and Lee JJ Patterns of recurrence following a negative sentinel lymph node biopsy in 243 patients with stage I or II melanoma Clin Oncol 1998, 16:2253-60
11. Reintgen DS, Cruse CW, Glass F and Fenske N In support of sentinel node biopsy as a standard of care for patients with malignant melanoma Dermatol Surg 2000, 26:1070-2
12. Qi D, Acker S, Kampalath B, Chang C, Komorowski R and Shidham VB Detection of Melanoma Micrometastases In Sentinel Lymph Nodes: Evaluation Of MART-1 and Melan-A In Comparison To Traditionally Used Immunomarkers Am J Clin Pathol 2000, 114:629-59 Abstract no.-8
13. Jungbluth AA, Iverson K, Coplan K, Kolb D, Stockert E, Chen YT, Old LJ and Busam K T311 - an anti-tyrosinase monoclonal antibody for the detection of melanocytic lesions in paraffin embedded tissues Pathol Res Pract 2000, 196(4):235-42
14. Shidham VB, Komorowski RA, Rao RN, Acker SM, Chang CC, Kampalath BN, Dawson G, Machhi JK and Qi DY Cocktail of three antibodies for the detection of micrometastases in sentinel lymph nodes of melanoma Mod Pathol 2002, 15:1A-368A Abstract no. 450
15. Beck JR and Shutz EK The use of relative operative characteristic (ROC) curves in test performance evaluation Arch Pathol Lab Med 1986, 110:13-20
16. McNeil BJ and Hanley JA Statistical approaches to the analysis of receiver operating characteristic (ROC) curves Med Decis Making 1984, 4:137-50
17. Raab SS Diagnostic accuracy in cytopathology Diagn Cytopathol 1994, 10:68-75
18. Raab SS, Thomas PA, Lenel JC, Bottles K, Fitzsimmons KM, Zaleski MS, Wittchow RJ, McPhaul LW, Slagel DD and Cohen MB Pathology and probability. Likelihood ratios and receiver operating characteristic curves in the interpretation of bronchial brush specimens Am J Clin Pathol 1995, 103:588-93
19. Shidham VB, Gupta D, Galindo L, Haber M, Grotkowski C, Edmonds P, Subichin SJ, George V and England J Intraoperative scrape cytology: Comparison with frozen section using probabilistic statistical method Diag Cytopathol 2000, 23:134-39
20. DeLong ER, DeLong DM and Clarke-Pearson DL Comparing the areas under two or more correlated receiver operating characteristic curves: A nonparametric approach Biometrics 1988, 44:837-45
21. Cochran AJ Surgical pathology remains pivotal in the evaluation of 'sentinel' lymph nodes Am J Surg Pathol 1999, 2310:1169-72
22. Miettinen M, Fernandez M, Franssila K, Gatalica Z, Lasota J and Sarlomo-Rikala M Microphthalmia transcription factor in the immunohistochemical diagnosis of metastatic melanoma: comparison with four other melanoma markers Am J Surg Pathol 2001, 25:205-11
23. Fontaine D, Parkhill W, Greer W and Walsh N Nevus cells in lymph nodes: an association with congenital cutaneous nevi Am J Dermatopathol 2002, 24:1-5
24. Blaheta HJ, Ellwanger U, Schittek B, Sotlar K, MacZey E, Breuninger H, Thelen MH, Bueltmann B, Rassner G and Garbe C Examination of regional lymph nodes by sentinel node biopsy and molecular analysis provides new staging facilities in primary cutaneous melanoma J Invest Dermatol 2000, 114:637-42
25. Blaheta HJ, Paul T, Sotlar K, Maczey E, Schittek B, Paul A, Moehrle M, Breuninger H, Bueltmann B, Rassner G and Garbe C Detection of melanoma cells in sentinel lymph nodes, bone marrow and peripheral blood by a reverse transcription-polymerase chain reaction assay in patients with primary cutaneous melanoma: association with Breslow's tumour thickness Br J Dermatol 2001, 145:195-202
26. Ghossein R and Rosai J Polymerase chain reaction in the detection of micrometastases and circulating tumor cells Cancer 1996, 78:10-6
27. Messina JL, Glass LF, Cruse CW, Berman C, Ku NK and Reintgen DS Pathologic examination of the sentinel lymph node in malignant melanoma Am J Surg Pathol 1999, 23:686-90
28. Shivers SC, Wang X, Li W, Joseph E, Messina J, Glass LF, DeConti R, Cruse CW, Berman C, Fenske NA, Lyman GH and Reintgen DS Molecular staging of malignant melanoma: correlation with clinical outcome JAMA 1998, 280:1410-5
29. Sung J, Li W, Shivers S and Reintgen D Molecular analysis in evaluating the sentinel node in malignant melanoma Ann Surg Oncol 2001, 8(9 Suppl):29S-30S
30. Treseler PA and Tauchi PS Sentinel lymph nodes in human solid cancer. Pathologic analysis of the sentinel lymph node Surg Clin North Am 2000, 80:1695-19
31. Farshid G, Pradhan M, Kollias J and Gill PG Computer simulations of lymph node metastasis for optimizing the pathologic examination of sentinel lymph nodes in patients with breast carcinoma Cancer 2000, 89:2527-37